Emcure Pharmaceuticals Limited (NSE:EMCURE)
India · Delayed Price · Currency is INR 2,334.40
+102.00 (4.57%)
Nov 12, 2026, 3:30 PM IST
Emcure Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Emcure Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of ₹2,423. The average 1-year stock price forecast is 3.77% higher than the current stock price, while the lowest is ₹2,150 (-7.90%) and the highest is ₹2,751 (+17.85%).
Price Target: ₹2,423 (+3.77%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Aug 12, 2026.
Analyst Ratings
The average analyst rating for Emcure Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains ₹2,100 → ₹2,320 | Buy | Maintains | ₹2,100 → ₹2,320 | -0.62% | Aug 12, 2026 |
Financial Forecast
Revenue This Year
110.81B
from 92.04B
Increased by 20.40%
Revenue Next Year
122.50B
from 110.81B
Increased by 10.55%
EPS This Year
66.31
from 52.29
Increased by 26.81%
EPS Next Year
80.39
from 66.31
Increased by 21.24%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.